NCT06745414View on ClinicalTrials.gov

Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Gastrointestinal Infection
Trial Locations (1)

Unknown

QIAGEN, Manchester

All Listed Sponsors
lead

QIAGEN Gaithersburg, Inc

INDUSTRY

NCT06745414 - Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2 | Biotech Hunter | Biotech Hunter